tiprankstipranks
Trending News
More News >
Voyager Therapeutics Inc. (VYGR)
NASDAQ:VYGR
US Market

Voyager Therapeutics (VYGR) Cash flow

Compare
1,320 Followers

Voyager Therapeutics Cash Flow

VYGR's free cash flow for Q3 2025 was $-31.25M. For the 2025 fiscal year, VYGR's free cash flow was decreased by $-93.49M and operating cash flow was $-31.05M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -15.31M$ 77.92M$ -12.51M$ -53.52M$ -96.72M
Investing Cash Flow
$ -94.86M$ -141.64M$ -7.34M$ 65.91M$ 113.00M
Financing Cash Flow
$ 114.02M$ 33.65M$ 1.11M$ 612.00K$ 3.16M
End Cash Position
$ 74.24M$ 70.39M$ 98.96M$ 117.43M$ 104.44M
Free Cash Flow
$ -18.83M$ 74.66M$ -15.00M$ -55.13M$ -108.81M
Currency in USD

Voyager Therapeutics Cash Flow